BRAF and melanoma: We used one melanoma cell line (SK-MEL-28 from ATCC) carrying the pathogenic mutations in EGFR, BRAF, and PTEN (https://maayanlab.cloud/SK-MEL-28, accessed on 10 January 2023) as a positive control.